Effectiveness of a diabetic self-management education intervention through WhatsApp for people with type 2 diabetes: A randomised controlled feasibility study

Not Applicable

• Conditions: Type 2 Diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12621001672842
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-07
• Last Update Posted: 5 December 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

•Males or females diagnosed with T2DM and regularly followed up at the diabetic centres.
•Male or female aged 18 to 60 years old.
•HbA1C greater than 9 % (Universally considered poor control)
•Patients are willing to participate in the study and have the capacity to provide informed consent.
•Agree to follow the study procedures
•Can Speak and read Arabic
•Can to access and use WhatsApp

Exclusion Criteria

•People with T1DM or gestational diabetes
•People who have participated in any other clinical trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-efficacy assessed by using UK-Diabetic Management Self-Efficacy Scale (UK-DMSES)'[UK-DMSES will assessed at baseline, immediately post-intervention (at 8th week), and 3 months post-intervention completion];Diabetic knowledge assessed by using Diabetic Knowledge Test (DKT)[DKT will assessed at baseline, immediately post-intervention (at 8th week ), and 3 months post-intervention completion]

Secondary Outcome Measures

Name	Time	Method
HbA1c assessed by blood test [HbA1c will assessed at baseline, immediately post-intervention (at 8th week), and 3 months post-intervention completion.];Anxiety and Depression assessed by using Hospital Anxiety and Depression Scale (HADS)[HADS will assessed at baseline, immediately post-intervention (at 8th week ), and 3 months post-intervention completion];Quality of life assessed by using Diabetes Management Quality of Life (DMQOL)[DMQOL will assessed at baseline, immediately post-intervention (at 8th week ), and 3 months post-intervention completion]